Biomerica Inc

NASDAQ:BMRAUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Contact Information

Headquarters

17571 VON KARMAN AVENUEIRVINE, CA, United States 92614

Phone

949-379-2875

Fax

949-553-1231

Executives

Chief Executive Officer, Director

Zackary Irani

Executive Vice Chairperson of the Board and Corporate Secretary

Allen Barbieri

Chief Financial Officer

Gary Lu

Independent Director

Catherine Coste

Independent Director

Jane Emerson